Adverse Drug Reactions of Tyrosine Kinase Inhibitors in the Treatment of Advanced Lung Cancer

Journal Title: International Journal of Medical Research Professionals - Year 2018, Vol 4, Issue 5

Abstract

Introduction: Erlotinib and gefitinib are the most commonly used epidermal growth factor receptor‑tyrosine kinase inhibitors (EGFR‑TKIs) in the treatment of EGFR mutant nonsmall cell lung cancer (NSCLC). Both erlotinib and gefitinib have shown equal efficacy in terms of response rates and overall survival. Hence, their toxicity profile becomes the most important determining factor in choosing these agents when treating EGFR mutant NSCLC. In this study, we compared the toxicity profile of erlotinib and gefitinib among an Indian subset of lung cancer patients. Materials and Methods: In this prospective nonrandomized study, 85 patients came at Acharya Tulsi Regional Cancer Treatment & Research Institute with NSCLC were tested for EGFR mutation status, and EGFR mutant patients were started on either erlotinib or gefitinib. They were periodically monitored for drug toxicities. Results: Out of the 85 patients tested, 34 patients were positive for EGFR mutation. Eleven of them were started on erlotinib and 23 were started on gefitinib. The most common side effect of TKIs was skin rash. Nine out of the 11 patients started on erlotinib and 7 of the 23 patients started on gefitinib had skin rash. Grade 3 and 4 skin rash was significantly more among patients treated with erlotinib which resulted in treatment delays. Other side effects of TKIs such as diarrhea and deranged liver functions were similar among the both subsets of patients. Conclusion: Skin toxicity is the major and serious side effect with erlotinib among Indian patients with EGFR mutant lung cancer. This resulted in significant treatment delay, which might adversely affect the overall survival of patients. Gefitinib was better tolerated and had a safer toxicity profile compared to erlotinib in Indian patients.

Authors and Affiliations

Pankaj Tantia, Ritika Agarwal, Jitendra Acharya

Keywords

Related Articles

Awareness of Dental Interns in Managing Cases of Pregnant Women at DUHS, Karachi

Introduction: Dental interns need to be trained in managing cases of every aspect. Pregnant patients are commonly seen in dental OPD and therefore it is imperative for interns to have sufficient knowledge and understandi...

A Clinical Audit of Fresh Frozen Plasma request in a Tertiary Care Hospital Of North-Western India

Introduction: Clinical audit of Fresh Frozen Plasma (FFP) uses is having a major role in improving the quality of transfusion services, as patients receiving Fresh Frozen Plasma unnecessarily will have the risk of allerg...

A Prospective Study on Use of Ilizarov Ring Fixator in Management of Nonunion of Long Bone

Introduction: The aim of treatment of non-union is to achieve a stable union without residual infection, deformities or shortening. The various techniques that are used in the treatment of non-union have all produced inc...

Evaluation of Knowledge, Risk Factors, Perceived Barriers, Attitude and Screening Practice of Colorectal Cancer among Tabuk Population, Saudi Arabia-2017

Introduction: In Tabuk region, colorectal cancer (CRC) ranked the first among male and the third among female. Therefore, the current study was carried out to investigate the extent of both knowledge and attitude toward...

Evaluation of Safety, Efficacy and Expulsion of Post-Placental and Intra-Cesarean Insertion of Intrauterine Contraceptive Devices (PPIUCD)

Background: This study examines to describe the factors associated with acceptability of immediate PPIUCD insertion in women according to their socio-demographic and obstetrics characteristics, and future pregnancy desir...

Download PDF file
  • EP ID EP537146
  • DOI 10.21276/ijmrp.2018.4.5.064
  • Views 87
  • Downloads 0

How To Cite

Pankaj Tantia, Ritika Agarwal, Jitendra Acharya (2018). Adverse Drug Reactions of Tyrosine Kinase Inhibitors in the Treatment of Advanced Lung Cancer. International Journal of Medical Research Professionals, 4(5), 283-285. https://europub.co.uk/articles/-A-537146